Observed arrival · 2026-10-25
oncolabels: EU cancer-drug labels, indexed
A free reference organizes EU-approved cancer-drug indications by tumour and biomarker, with cutoffs, treatment lines, regimens, and wording from EMA product information.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Pathologists, oncologists, and cancer researchers
- Worth noticing
- The site says its entries are AI-generated and have not yet been reviewed by a person; classic chemotherapy is excluded.
Field notes
The homepage organizes its indexes into tumour, biomarker, and drug views, with counts such as 83 non-small cell lung cancer indications and 36 PD-L1 indications. It says the underlying material comes from 180 EMA product-information documents, which change every few weeks. The site describes its entries as AI-generated and not yet reviewed by a person, a material limitation for interpreting this medical reference.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
●ProPolished or operationally mature
◎NicheUnusually specific use
One card from the complete issue